作者:
Treister,N. [1]
;
Chai,X. [2]
;
Kurland,B. [3]
;
Pavletic,S. [4]
;
Weisdorf,D. [5]
;
Pidala,J. [6]
;
Palmer,J. [7]
;
Martin,P. [8]
;
Inamoto,Y. [9]
;
Arora,M. [10]
;
Flowers,M. ;
Jacobsohn,D. ;
Jagasia,M. ;
Arai,S. ;
Lee,S.J. ;
Cutler,C.
作者单位:
Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA, United States
[1]
Department of Medicine, University of Minnesota, Minneapolis, MN, United States
[2]
Department of Blood and Marrow Transplantation, Moffitt Cancer Center, Tampa, FL, United States
[3]
Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, United States
[4]
Division of Blood and Marrow Transplantation, Center for Cancer and Blood Disorders, Children's
[5]
Division of Blood and Marrow Transplantation, Stanford University Medical Center, Stanford, CA
[6]
Division of Hematology, Stem Cell Transplantation, Vanderbilt Ingram Cancer Center, Nashville, TN
[7]
Experimental Transplantation and Immunology Branch, National Cancer Institute, Center for Cancer
[8]
Division of Oral Medicine and Dentistry, Brigham and Women's Hospital, 1620 Tremont Street, Boston
[9]
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States
[10]
发布时间
2013-12-19